The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Evaluate historical worst drawdowns for index funds and translate insights into practical risk controls and withdrawal planning.
14,434 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
A large investment fund recently exited its stake in Asbury Automotive, triggering headlines about insider selling. T...
Cryptocurrencies attract big headlines and big hopes. This guide takes a calm, practical look at XRP and shows you a ...
A sweeping regulatory update defines most cryptocurrencies as commodities or digital tools, sparking a rally in crypt...
Federal health officials issued a warning about misleading statements from biotech billionaire Patrick Soon-Shiong re...
In 2026, many adults and teens feel pressure from online peers to keep up with trends, upgrade gadgets, or join paid ...
Federal regulators capped Eversource’s base ROE, creating a near-term earnings hurdle even as the utility doubles dow...
European defense funding is moving to multi-year commitments, reshaping orders for European and U.S. defense contract...
In a high-stakes run-up to the 2026 elections, Donald Trump’s endorsements are reshaping GOP primaries and donor beha...
A sudden price glitch on a popular trading app sent bitcoin price crashes near zero for a moment, leaving traders puz...
SUI surged 37% over the past seven days, powered by institutional staking inflows and a protocol upgrade that enables...
Elliptic closes a $120 million Series D at a $670 million post-money valuation, with Deutsche Bank and Nasdaq Venture...